Effect of pharmacist pain review and CBT intervention on outcomes

  • Research type

    Research Study

  • Full title

    The effect of pharmacist involvement with a pain review clinic coupled with Cognitive Behaviour Therapy input on pain medication outcomes.

  • IRAS ID

    200349

  • Contact name

    Brian McCaw

  • Contact email

    b.mccaw@qub.ac.uk

  • Sponsor organisation

    Queen's University Belfast

  • Duration of Study in the UK

    0 years, 1 months, 13 days

  • Research summary

    The aim of this research is to evaluate if using a pharmacist medication review clinic combined with a Cognitive behaviour therapy component can have a positive impact on patient’s perception of chronic pain and reduce the use of opioid and neuropathic analgesics.\nThis research will be carried out in a GP surgery.\nPatients using analgesics for a prolonged period (more than 2 years) or using multiple opioids or neuropathic analgesics will be asked to complete: A Brief Pain Inventory (BPI) ;Depression, Anxiety and Stress Scales (DASS-21) and Pain Self Efficacy Questionnaires by the pharmacist. A copy of the ’Pain Toolkit’ by Pete Moore will also be given.\nThe Cognitive Behaviour Therapist will carry out 6 sessions of 75 minutes with the group (called the Pain Awareness group).The sessions include: Learning how to do things differently; Acceptance, Pacing and positive focusing skills; Combatting negative thoughts; Introducing positive changes to reduce pain and fatigue.\nThere will then be a pharmacist medication review and further copies of the questionnaires will be given. Patients pain medication will be reviewed and rationalised/reduced where appropriate. The pharmacist will remain a GP surgery point of contact. There is also the possibility of developing a patient expert group on pain.

  • REC name

    HSC REC A

  • REC reference

    16/NI/0122

  • Date of REC Opinion

    18 Jul 2016

  • REC opinion

    Further Information Favourable Opinion